ArticleFrontiers in oncology2021

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center.

Shuguang Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.